Explore recursive self-improvement, agentic AI risks and the AI singularity debate, including OpenAI security incidents and ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Researcher believes overprivileged Iterable creds exposed 8.8M customer records – and could have enabled mass deletion ...
GitHub Copilot's Project HydraFusion Promises Frontier Level Performance Through Multi-Model Routing
GitHub's Project HydraFusion is a research preview for GitHub Copilot that enhances coding intelligence through runtime model ...
The latest from Paul Schrader, the Dardenne brothers, and Hirokazu Kore-eda stud our latest dispatch from the fest.
HyperVerge today launched a suite of AI agents for business loan underwriting at the Global Fintech Fest 2026. Built to close India’s ₹25 lakh crore credit gap for MSMEs, the suite of three AI agents ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results